Why the study?
Does the re-entry vulnerability index (RVI) predict the breakout site of VT and clinical events in patients with ARVC, Brugada Syndrome, or focal RV outflow tract VT?
Does the re-entry vulnerability index (RVI) predict the breakout site of VT and clinical events in patients with ARVC, Brugada Syndrome, or focal RV outflow tract VT?
The re-entry vulnerability index (RVI) can localize the origin of re-entrant ventricular arrhythmias in ARVC and Brugada Syndrome and predict future clinical VT events, offering a potential tool for targeted ablation and ICD risk stratification.
Background: Initiation of re-entrant ventricular tachycardia (VT) involves complex interactions between activation (AT) and repolarization times (RT). The re-entry vulnerability index (RVI) is a recently proposed activation-repolarization metric designed to quantify tissue susceptibility to re-entry. Objectives: The study aimed to test the feasibility of an RVI-based algorithm to predict the breakout site of VT and occurrence of clinical events. Methods: Patients with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) (n=11), Brugada Syndrome (BrS) (n=13) and focal RV outflow tract VT (n=9) underwent programmed stimulation with unipolar electrograms recorded from a non-contact array. The distance between region of lowest RVI and site of VT breakout (Dmin), and global minimum RVI (RVIG) were computed to assess prediction of site of VT breakout and occurrence of clinical events, respectively. Results: Lowest values of RVI, representing sites of highest susceptibility to re-entry, co-localised with site of VT breakout in ARVC/BrS but not in focal VT and Dmin values were lower in ARVC/BrS. ARVC/BrS patients with inducible VT had lower RVIG than those who were non-inducible or those with focal VT. Patients were followed up for 112 +/- 19 months; those with clinical VT events had lower RVIG than those without VT or those with focal VT. Conclusions: The proposed methodology based on RVI localises the origin of re-entrant but not focal ventricular arrhythmias and predicts clinical events. This index could be applied to target ablation for arrhythmias which are difficult to induce or are haemodynamically unstable and also risk stratify patients for ICD prophylaxis.
No takes yet. Share an insight, caveat, or question.
Martin et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: